ERBB2 and breast carcinoma: Molecular analysis of breast cancer based on the gene expression profile (e.g., estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2)) has enabled the classification of BC into different subtypes, such as luminal A, luminal B, HER2 and basal (or triple negative BC) types of breast cancers.